These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26670081)

  • 1. Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities.
    Chekler EL; Pellegrino JA; Lanz TA; Denny RA; Flick AC; Coe J; Langille J; Basak A; Liu S; Stock IA; Sahasrabudhe P; Bonin PD; Lee K; Pletcher MT; Jones LH
    Chem Biol; 2015 Dec; 22(12):1588-96. PubMed ID: 26670081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.
    Hay DA; Fedorov O; Martin S; Singleton DC; Tallant C; Wells C; Picaud S; Philpott M; Monteiro OP; Rogers CM; Conway SJ; Rooney TP; Tumber A; Yapp C; Filippakopoulos P; Bunnage ME; Müller S; Knapp S; Schofield CJ; Brennan PE
    J Am Chem Soc; 2014 Jul; 136(26):9308-19. PubMed ID: 24946055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.
    Romero FA; Taylor AM; Crawford TD; Tsui V; Côté A; Magnuson S
    J Med Chem; 2016 Feb; 59(4):1271-98. PubMed ID: 26572217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening.
    Zhang FC; Sun ZY; Liao LP; Zuo Y; Zhang D; Wang J; Chen YT; Xiao SH; Jiang H; Lu T; Xu P; Yue LY; Du DH; Zhang H; Liu CP; Luo C
    Acta Pharmacol Sin; 2020 Feb; 41(2):286-292. PubMed ID: 31253937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition.
    Ghosh S; Taylor A; Chin M; Huang HR; Conery AR; Mertz JA; Salmeron A; Dakle PJ; Mele D; Cote A; Jayaram H; Setser JW; Poy F; Hatzivassiliou G; DeAlmeida-Nagata D; Sandy P; Hatton C; Romero FA; Chiang E; Reimer T; Crawford T; Pardo E; Watson VG; Tsui V; Cochran AG; Zawadzke L; Harmange JC; Audia JE; Bryant BM; Cummings RT; Magnuson SR; Grogan JL; Bellon SF; Albrecht BK; Sims RJ; Lora JM
    J Biol Chem; 2016 Jun; 291(25):13014-27. PubMed ID: 27056325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain.
    Brand M; Clayton J; Moroglu M; Schiedel M; Picaud S; Bluck JP; Skwarska A; Bolland H; Chan AKN; Laurin CMC; Scorah AR; See L; Rooney TPC; Andrews KH; Fedorov O; Perell G; Kalra P; Vinh KB; Cortopassi WA; Heitel P; Christensen KE; Cooper RI; Paton RS; Pomerantz WCK; Biggin PC; Hammond EM; Filippakopoulos P; Conway SJ
    J Med Chem; 2021 Jul; 64(14):10102-10123. PubMed ID: 34255515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitors of bromodomain-acetyl-lysine interactions.
    Brand M; Measures AR; Wilson BG; Cortopassi WA; Alexander R; Höss M; Hewings DS; Rooney TP; Paton RS; Conway SJ
    ACS Chem Biol; 2015 Jan; 10(1):22-39. PubMed ID: 25549280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain.
    Unzue A; Xu M; Dong J; Wiedmer L; Spiliotopoulos D; Caflisch A; Nevado C
    J Med Chem; 2016 Feb; 59(4):1350-6. PubMed ID: 26043365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.
    Sachchidanand ; Resnick-Silverman L; Yan S; Mutjaba S; Liu WJ; Zeng L; Manfredi JJ; Zhou MM
    Chem Biol; 2006 Jan; 13(1):81-90. PubMed ID: 16426974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands.
    Jennings LE; Measures AR; Wilson BG; Conway SJ
    Future Med Chem; 2014 Feb; 6(2):179-204. PubMed ID: 24467243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics.
    Xu M; Unzue A; Dong J; Spiliotopoulos D; Nevado C; Caflisch A
    J Med Chem; 2016 Feb; 59(4):1340-9. PubMed ID: 26125948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Fragments for the CREBBP Bromodomain Identified from an Encoded Self-assembly Chemical Library.
    Catalano M; Moroglu M; Balbi P; Mazzieri F; Clayton J; Andrews KH; Bigatti M; Scheuermann J; Conway SJ; Neri D
    ChemMedChem; 2020 Sep; 15(18):1752-1756. PubMed ID: 32686307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of tetrahydroquinolin derivatives as potent inhibitors of CBP bromodomain.
    Chen Y; Bi X; Zhang F; Sun Z; Xu P; Jiang H; Lu W; Lu T; Ding H; Zhang N; Jiang H; Chen K; Zhou B; Luo C
    Bioorg Chem; 2020 Aug; 101():103991. PubMed ID: 32559581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromodomains and their pharmacological inhibitors.
    Gallenkamp D; Gelato KA; Haendler B; Weinmann H
    ChemMedChem; 2014 Mar; 9(3):438-64. PubMed ID: 24497428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based drug optimization and biological evaluation of tetrahydroquinolin derivatives as selective and potent CBP bromodomain inhibitors.
    Bi X; Chen Y; Sun Z; Lu W; Xu P; Lu T; Ding H; Zhang N; Jiang H; Chen K; Zhou B; Luo C
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127480. PubMed ID: 32882416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomains: pockets with therapeutic potential.
    Papavassiliou KA; Papavassiliou AG
    Trends Mol Med; 2014 Sep; 20(9):477-8. PubMed ID: 24986769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.
    Theodoulou NH; Bamborough P; Bannister AJ; Becher I; Bit RA; Che KH; Chung CW; Dittmann A; Drewes G; Drewry DH; Gordon L; Grandi P; Leveridge M; Lindon M; Michon AM; Molnar J; Robson SC; Tomkinson NC; Kouzarides T; Prinjha RK; Humphreys PG
    J Med Chem; 2016 Feb; 59(4):1425-39. PubMed ID: 25856009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.
    Borah JC; Mujtaba S; Karakikes I; Zeng L; Muller M; Patel J; Moshkina N; Morohashi K; Zhang W; Gerona-Navarro G; Hajjar RJ; Zhou MM
    Chem Biol; 2011 Apr; 18(4):531-41. PubMed ID: 21513889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screen to NMR (VS2NMR): Discovery of fragment hits for the CBP bromodomain.
    Spiliotopoulos D; Zhu J; Wamhoff EC; Deerain N; Marchand JR; Aretz J; Rademacher C; Caflisch A
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2472-2478. PubMed ID: 28410781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phenotypic screening assay for modulators of huntingtin-induced transcriptional dysregulation.
    Lazzeroni G; Benicchi T; Heitz F; Magnoni L; Diamanti D; Rossini L; Massai L; Federico C; Fecke W; Caricasole A; La Rosa S; Porcari V
    J Biomol Screen; 2013 Oct; 18(9):984-96. PubMed ID: 23562876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.